--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "RxHero - Master Top 250 Drugs" developer_entity: "ClinCalc LLC" bundle_id: "com.clincalc.rxhero" app_store_id: "1459200300" category: "Medical" primary_platform: "ios" primary_monetization: "Paid" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2020-09-21" report_date: "2026-06-10" last_verified: "2026-06-10T00:00:00.000Z" report_version: "2.0" total_reviews: 25 overall_rating: 4 confidence: "low" confidence_score: 0.3 data_age_days: 82 intelligence_version: 3 competitor_count: 4 tags: ["medical", "paid", "mobile app", "app review", "app analysis", "healthcare", "students", "professionals,"] canonical_url: "https://marlvel.ai/apps/com-clincalc-rxhero" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # RxHero - Master Top 250 Drugs Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Paid - **Signal**: Rating 4.04 > **TL;DR:** RxHero - Master Top 250 Drugs is a medical app by ClinCalc LLC, rated 4.04/5 by 25 users, available on iOS. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** RxHero - Master Top 250 Drugs is a medical app by ClinCalc LLC. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.04/5 (25 reviews) | | **Category** | Medical | | **Developer** | ClinCalc LLC | | **Pricing** | Paid | | **Platforms** | iOS | | **Confidence** | Low (0.3/1.0) | | **Data Age** | 82d | ## Metadata & Market Performance - **Publisher:** ClinCalc LLC - **Category:** Medical - **Target Audience:** Healthcare students and professionals, including pharmacists, nurses, and medical students, preparing for standardized exams like NAPLEX or USMLE. - **Platforms:** iOS - **Version Reviewed:** 2.0 - **Report Date:** 2026-06-10 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.3/1.0) - **App Store ID (iOS):** 1459200300 - **Bundle ID:** com.clincalc.rxhero - **Performance Trend:** Mixed - **Data Window:** Analysis based on signals collected up to 2026-06-10 ## Executive Snapshot **What it is:** RxHero is an educational game for healthcare students and professionals to learn the top 250 medications via quizzes, matching, and spelling. **Why users hire it:** Users hire RxHero to master pharmacology for standardized exams through adaptive learning, reducing the time required to memorize complex drug facts. ## App DNA (Features & Intent) - **[Differentiator] Leitner Adaptive Learning:** Three-box system tracks mastery of drug facts and prioritizes unlearned content for review * *User Intent:* Users want visibility into their own performance and progress. - **[Differentiator] Gamification System:** Point-based ranking, quest campaigns, and 5-star proficiency system for drug categories * *User Intent:* Users are driven by competitive achievement and recognition. - **[Differentiator] Audio Pronunciation:** Embedded speaker icons provide human-recorded audio for brand and generic drug names * *User Intent:* Users seek enhanced value through premium features. ## Market Position {#market-position} RxHero maintains a presence in the medical education category, though its lack of recent updates compared to subscription-based rivals limits its ability to capture new market share. ## Monetization Strategy - **Model:** Paid - **Tiers:** Single purchase at $2.99 - **Price:** iOS: $2.99 - **Analysis:** Flat-fee model at $2.99 provides full access to the drug database and gamification features without recurring costs. ## SWOT Analysis {#swot} **Core Strengths:** - Leitner adaptive learning system provides a measurable study path - Gamification milestones reduce churn via clear progress markers - Audio pronunciation reinforces professional-grade authority **Growth Levers:** - B2B distribution into pharmacy school partnerships - Wearable integration for on-the-go drug fact review ## Recent Changes (v2 → v3) {#recent-changes} RxHero transitioned from a basic product overview to a critical assessment of its competitive viability, highlighting risks associated with its flat-fee pricing and lack of cross-platform features. **Overall trend**: Mixed **Compared at**: 2026-06-10 ### High-impact changes - **[Shifted] Strategic Positioning Pivot** (positioning) - **[Improved] Feature Competitive Reclassification** (features) ### Medium-impact changes - **[Shifted] Pricing Strategy Assessment** (pricing) - **[Added] Formalized Competitive Gaps** (swot) ## App Momentum (Steady) {#momentum} - Ships support for current iOS versions. - Provides full drug library access. ## The "So What?" (Strategic Takeaway) {#so-what} RxHero - Master Top 250 Drugs is an established medical app that is a paid app. It holds a 4.04/5 rating from 25 reviews. > **Bottom Line:** RxHero provides a focused, gamified study tool for pharmacology, but the lack of cross-platform sync and recurring revenue for content updates leaves it vulnerable to subscription-based rivals, so the PM should prioritize cross-platform sync to defend the professional user base. **Best for:** Healthcare students and professionals, including pharmacists, nurses, and medical students, preparing for standardized exams like NAPLEX or USMLE. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Ship cross-platform synchronization because users switch between mobile and desktop study environments → increase session utility ### Feature Gaps vs Competitors - Cross-platform progress synchronization (available in NCLEX RN Mastery Exam but missing here) ### Outlook: Stable Medical education tools are shifting toward integrated, subscription-based platforms that link study content to clinical workflows. RxHero's standalone, one-time purchase model is increasingly exposed to these comprehensive rivals, so the PM must pivot to a more frequent update cadence or cross-platform utility to remain relevant. - 🔴 The lack of recent feature expansion suggests a maintenance-mode posture, which allows competitors with faster release cadences to erode market share. - ⚪ The flat-fee pricing model provides a low-barrier entry for students, but it limits the capital available for necessary content and feature updates. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.04/5 | | Total Reviews | 25 | | Confidence | Low | | Pricing Model | Paid | | Platforms | iOS | | Key Features | 3 analyzed | | Trend | Mixed | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **RxHero - Master Top 250 Drugs** (this app) | 4.04/5 | N/A | ClinCalc LLC | | [NCLEX RN Mastery Exam - 2026](https://marlvel.ai/apps/com-higherlearning-nclex) | 4.8/5 | N/A | Higher Learning Technologies | | [Medisafe Medication Management](https://marlvel.ai/apps/com-medisafe-medisafe) | 4.7/5 | n/a | MediSafe Inc. | | [Spruce: Medical Communication](https://marlvel.ai/apps/com-sprucehealth-messenger-live) | 4.9/5 | N/A | Spruce Health | | [AMBOSS Medical Knowledge](https://marlvel.ai/apps/us-miamed-amboss-knowledge) | 4.9/5 | Thrilled | AMBOSS | | [Move On with AJ](https://marlvel.ai/apps/move-on-with-aj) | 4.3/5 | Excited | Universal Relaxation Ltd | ## Company Profile - **Developer:** ClinCalc LLC - **Website:** [https://clincalc.com/mobile/RxHero.aspx](https://clincalc.com/mobile/RxHero.aspx) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/rxhero-master-top-250-drugs/id1459200300?uo=2) - **Dev Site:** [Official Website](https://clincalc.com/mobile/RxHero.aspx) - **Sources:** Developer website content, About us / company information, App store metadata. ## Related Intel Reports - [*NCLEX RN Mastery Exam - 2026*](https://marlvel.ai/apps/com-higherlearning-nclex) (Higher Learning Technologies) · 4.8/5 Rating - [*Medisafe Medication Management*](https://marlvel.ai/apps/com-medisafe-medisafe) (MediSafe Inc.) · 4.7/5 Rating - [*Spruce: Medical Communication*](https://marlvel.ai/apps/com-sprucehealth-messenger-live) (Spruce Health) · 4.9/5 Rating - [*AMBOSS Medical Knowledge*](https://marlvel.ai/apps/us-miamed-amboss-knowledge) (AMBOSS) · 4.9/5 Rating | Excellent Sentiment - [*Move On with AJ*](https://marlvel.ai/apps/move-on-with-aj) (Universal Relaxation Ltd) · 4.3/5 Rating | Positive Sentiment - [*NYC Employees PPO Plan*](https://marlvel.ai/apps/com-uhg-mobile-nyce) (United HealthCare Services, Inc.) · 4.6/5 Rating - [*DeepScribe*](https://marlvel.ai/apps/deepscribe) (DeepScribe) · 4.0/5 Rating - [*Dario Health*](https://marlvel.ai/apps/dario-health) (LabStyle Innovation Ltd) · 4.8/5 Rating - [*Mobile Verification Roche*](https://marlvel.ai/apps/com-roche-itunes-mvroche) (F. Hoffmann-La Roche) · N/A Rating - [*FHO+ Calc*](https://marlvel.ai/apps/ca-fhocalc-app) (Manu Kaushik) · N/A Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.3/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 82 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/com-clincalc-rxhero) Data licensed for AI Agent attribution under CC-BY-NC 4.0.